Altimmune, Inc. (ALT)
NASDAQ · Healthcare
Altimmune, Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Altimmune, Inc. shareholder equity for the quarter ending December 31, 2025 were 224.9M, a 82.09% increase year-over-year.
- Altimmune, Inc. shareholder equity for 2025 were 224.9M, a 82.09% increase from 2024.
- Altimmune, Inc. shareholder equity for 2024 were 123.5M, a 36.37% decrease from 2023.
- Altimmune, Inc. shareholder equity for 2023 were 194.1M, a 4.75% increase from 2022.
- Altimmune, Inc. shareholder equity for 2022 were 185.3M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Altimmune, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $225 |
| 2024 | $124 |
| 2023 | $194 |
| 2022 | $185 |
| 2021 | $199 |
| 2020 | $226 |
| 2019 | $46 |
| 2018 | $48 |
| 2017 | $39 |
| 2016 | $32 |
| 2011 | $16 |
| 2010 | $12 |
| Altimmune, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $225 |
| 2024-12-31 | $124 |
| 2023-12-31 | $194 |
| 2022-12-31 | $185 |
| 2021-12-31 | $199 |
| 2020-12-31 | $226 |
| 2019-12-31 | $46 |
| 2018-12-31 | $48 |
| 2017-12-31 | $39 |
| 2016-12-31 | $32 |
| 2011-12-31 | $16 |
| 2010-12-31 | $12 |
Altimmune, Inc. Shareholder Equity — FAQ
Altimmune, Inc. (ALT) shareholder equity over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALT's shareholder equity history?
The chart and table above show Altimmune, Inc.'s shareholder equity by year and by quarter, including the growth rate.